An experimental weight-loss pill helped people drop 13% of their body weight in a three-month period. The results from early ...

Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze.

Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that ...

The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that ...

A new weight loss pill developed by the maker of Ozempic and Wegovy helped overweight and obese people lose up to 13% of ...

Novo Nordisk’s American depositary receipts tumbled almost 6% Friday after the drugmaker reported mixed results from a study of an experimental weight-loss pill. The pill, monlunabant, helped people ...

Novo Nordisk reported that its new obesity pill led to substantial weight loss in an early study, boosting the company’s ...

A new drug called amycretin is stepping into the spotlight, boasting impressive results that have both researchers and those ...

A new weight loss pill called amycretin has helped people lose up to 13% of their body weight in just three months, according ...

Novo Nordisk, the maker of Ozempic and Wegovy, said its experimental weight-loss pill lowered participants' body weight by up ...

The drug manufacturer has developed a pill that could bring about weight loss of as much as 13% in three months, according to ...

WEDNESDAY, Sept. 11, 2024 (HealthDay News) -- The weight-loss drug liraglutide helped obese children lower their BMI and ...